Study Links GLP-1s to Lower Risk of Fragility Fractures in Diabetes Patients

MedPage Today

(MedPage Today) -- Starting a GLP-1 receptor agonist for type 2 diabetes was associated with a lower risk of fragility fractures in adults 50 and older, including hip and vertebral fractures, according to a large target trial emulation study....

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

Study Links GLP-1s to Lower Risk of Fragility Fractures in Diabetes Patients

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

The hunt for a natural molecule that can release cellular energy

Dealing with post-pandemic sleep issues—it's not too late

We talk with astronaut Michael Foale about the 1997 Space Station Mir crisis: 'He took all the blame of the collision on his shoulders'

MedPage Today의 다른 기사

This Year's Ebola Outbreak Has Spread Faster Than the Worst on Record

Branded Bevacizumab Approved for Wet AMD

FDA Panel Finds a Peptide It Doesn't Like